Jones Financial Companies’s Vanda Pharmaceuticals VNDA Stock Holding History

Jones Financial Companies’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.9K	Buy	+420	New	+$3.24K	﹤0.01%	4041

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jones Financial Companies's VNDA Position: Q1 2026 in Review

Jones Financial Companies opened a new position in Vanda Pharmaceuticals (VNDA) in Q1 2026: 420 shares worth $2.9K. The stake represents ﹤0.01% of the portfolio and ranks #4041 among its holdings.

170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

Jones Financial Companies held 420 shares of Vanda Pharmaceuticals worth $2.9K as of Q1 2026.
Vanda Pharmaceuticals was a new Jones Financial Companies position in Q1 2026.
Vanda Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4041 holding.
170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.